Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 3/20 | 0.93 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.93 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.93 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.93 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.93 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | FABP3 | P05413 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL10647607 | 0.97 | FFAR3 (0.88) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL192173 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL365970 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1618614 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL4816057 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL5049856 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL60746 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11430053 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11429689 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL9302539 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3006599-B1 | METHOD FOR COATING THE SURFACE OF A METAL SUBSTRATE | SAFRAN LANDING SYSTEMS (FR) | 2019-03-27 | — | — | EP | claimed |
| US-10066301-B2 | Method of coating the surface of a metal substrate | MESSIER-BUGATTI-DOWTY (FR) | 2018-09-04 | — | — | US | claimed |
| EP-2889284-B1 | METHOD FOR PRODUCING IRON CARBONATE | MITSUBISHI CHEM CORP (JP) | 2017-10-11 | — | — | EP | claimed |
| US-20160102406-A1 | METHOD OF COATING THE SURFACE OF A METAL SUBSTRATE | MESSIER-BUGATTI-DOWTY (FR) | 2016-04-14 | — | — | US | claimed |
| US-20150218080-A1 | METHOD FOR PRODUCING IRON CARBOXYLATE | MITSUBISHI RAYON CO., LTD. (JP) | 2015-08-06 | — | — | US | claimed |
| EP-2889284-A1 | METHOD FOR PRODUCING IRON CARBONATE | Mitsubishi Rayon Co., Ltd. (JP) | 2015-07-01 | — | — | EP | claimed |
| US-6486367-B1 | Process for the hydrogenation of maleic acid to 1,4-butanediol | THE STANDARD OIL COMPANY | 2002-11-26 | — | — | US | claimed |
| EP-0919530-B1 | Improved process for the hydrogenation of maleic acid to 1,4-butanediol | STANDARD OIL CO (US) | 2002-02-13 | — | — | EP | claimed |
| EP-0919530-A1 | Improved process for the hydrogenation of maleic acid to 1,4-butanediol | THE STANDARD OIL COMPANY (US) | 1999-06-02 | — | — | EP | claimed |
| US-5817616-A | 4,4-DIMETHYL-6-ISOPROPYL-1,2,3,4-TETRAHYDRONAPHTHALEN-1-ONE | NANJING FORESTRY UNIVERSITY (CN) | 1998-10-06 | — | — | US | claimed |
| US-4500719-A | Process for the preparation of N-alkenylphenylmaleimides and N,N'-[alkenylenephenylene]bismalemides | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1985-02-19 | — | — | US | claimed |
| US-4211882-A | OXIDIZING P-TOLUALDEHYDE, CATALYST CONSISTING OF A MANGANESE COMPOUND, A COBALT COMPOUND, A BROMINE COMPOUND, AND A NICKEL, IRON, CHROMIUM, OR LANTHANIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1980-07-08 | — | — | US | claimed |
| JP-62134083-A | — | — | None | — | — | JP | disclosed |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | HENKEL AG & CO KGAA (DE) | 2026-03-26 | — | — | US | disclosed |
| US-12540262-B2 | Two component (2K) curable adhesive composition | HENKEL AG & CO. KGAA (DE) | 2026-02-03 | — | — | US | disclosed |
| US-12473421-B2 | Ethylene-vinyl alcohol copolymer composition, pellets, and multilayer structure | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| EP-0600427-A1 | Optical information recording medium and composition for optical information recording film | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-06-08 | — | — | EP | disclosed |
| JP-S62134083-A | IRON-CONTAINING MICROORGANISM AND PRODUCTION THEREOF | IWAKI SEIYAKU KK | 1987-06-17 | — | — | JP | disclosed |
| US-4622069-A | Catalyst composition for forming electroless plating on ceramics | OKUNO CHEMICAL INDUSTRY CO., LTD. (JP) | 1986-11-11 | — | — | US | disclosed |
| US-4211882-A | OXIDIZING P-TOLUALDEHYDE, CATALYST CONSISTING OF A MANGANESE COMPOUND, A COBALT COMPOUND, A BROMINE COMPOUND, AND A NICKEL, IRON, CHROMIUM, OR LANTHANIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540262-B2 | Two component (2K) curable adhesive composition | ILK, MAT2A, MMAB | FFAR3 3167/4885HDAC3 2807/4885HDAC1 2575/4885 |
| US-20150218080-A1 | METHOD FOR PRODUCING IRON CARBOXYLATE | FECH, CA2, CA5B | FFAR3 1076/4885HDAC3 2346/4885HDAC1 3748/4885 |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | EPCAM, CDH1, ITGA4 | FFAR3 4176/4885HDAC3 3250/4885HDAC1 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.